Literature DB >> 12680372

Teriparatide.

Carilee Berg1, Kat Neumeyer, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12680372     DOI： 10.1038/nrd1068

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  11 in total

1.  Structure of class B GPCR corticotropin-releasing factor receptor 1.

Authors:  Kaspar Hollenstein; James Kean; Andrea Bortolato; Robert K Y Cheng; Andrew S Doré; Ali Jazayeri; Robert M Cooke; Malcolm Weir; Fiona H Marshall
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

2.  Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice.

Authors:  Philippe Clément-Lacroix; Minrong Ai; Frederic Morvan; Sergio Roman-Roman; Béatrice Vayssière; Cecille Belleville; Kenneth Estrera; Matthew L Warman; Roland Baron; Georges Rawadi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

Review 3.  Use of Teriparatide to improve fracture healing: What is the evidence?

Authors:  Satish Babu; Nemandra A Sandiford; Mark Vrahas
Journal:  World J Orthop       Date:  2015-07-18

4.  Water solution of onion crude powder inhibits RANKL-induced osteoclastogenesis through ERK, p38 and NF-kappaB pathways.

Authors:  C-H Tang; T-H Huang; C-S Chang; W-M Fu; R-S Yang
Journal:  Osteoporos Int       Date:  2008-05-28       Impact factor: 4.507

5.  Use of Backbone Modification To Enlarge the Spatiotemporal Diversity of Parathyroid Hormone Receptor-1 Signaling via Biased Agonism.

Authors:  Shi Liu; Frederic G Jean-Alphonse; Alex D White; Denise Wootten; Patrick M Sexton; Thomas J Gardella; Jean-Pierre Vilardaga; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2019-09-09       Impact factor: 15.419

6.  Fat's loss is bone's gain.

Authors:  Liming Pei; Peter Tontonoz
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

7.  SOST and DKK: Antagonists of LRP Family Signaling as Targets for Treating Bone Disease.

Authors:  James J Mason; Bart O Williams
Journal:  J Osteoporos       Date:  2010-07-01

8.  Antiosteoporotic Activity of Dioscorea alata L. cv. Phyto through Driving Mesenchymal Stem Cells Differentiation for Bone Formation.

Authors:  Kang-Yung Peng; Lin-Yea Horng; Hui-Ching Sung; Hui-Chuan Huang; Rong-Tsun Wu
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-29       Impact factor: 2.629

9.  Si-Wu-tang extract stimulates bone formation through PI3K/Akt/NF-κB signaling pathways in osteoblasts.

Authors:  Chi-Ming Wu; Po-Chun Chen; Te-Mao Li; Yi-Chin Fong; Chih-Hsin Tang
Journal:  BMC Complement Altern Med       Date:  2013-10-24       Impact factor: 3.659

10.  Controlling Arteriogenesis and Mast Cells Are Central to Bioengineering Solutions for Critical Bone Defect Repair Using Allografts.

Authors:  Ben Antebi; Longze Zhang; Dmitriy Sheyn; Gadi Pelled; Xinping Zhang; Zulma Gazit; Edward M Schwarz; Dan Gazit
Journal:  Bioengineering (Basel)       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.